Equine Department, Section of Ophthalmology, Vetsuisse Faculty, University of Zurich, Switzerland.
Equine Vet J. 2013 Sep;45(5):608-12. doi: 10.1111/evj.12042. Epub 2013 Mar 12.
Keratomycosis is a severe disease in horses. Geographical differences in fungi causing keratomycosis and susceptibility of the organisms to antifungal drugs exist but few previous publications on this disease originate from Europe.
To retrospectively compare the clinical data of 36 eyes with keratomycosis, diagnosed in 35 horses between January 2000 and August 2011 at the Vetsuisse Faculty of Switzerland. Case history, season, prior treatment, clinical appearance, surgical and medical treatment, treatment duration, and globe survival were evaluated.
Retrospective case series.
Medical records of horses with a definitive cytological or histological diagnosis of keratomycosis were reviewed.
Thirty-one of 36 eyes (86.1%) presented with ulcerative keratitis, 2/36 (5.55%) had diffuse corneal infiltration, 2/36 (5.55%) had superficial punctate keratitis and 1/36 (2.8%) had a fluorescein-negative fungal plaque. Two of 6 fungal cultures produced Aspergillus spp. Thirty eyes received medical and surgical treatment, while 3 eyes were treated medically only. In 3 horses the globe was removed at the time of first presentation. Sex, age, prior treatment with antimicrobials or steroids, or type of surgical approach did not significantly influence the outcome. Twenty-three of 36 eyes (63.9%) were at least partially visual, 11/36 eyes (30.5%) were enucleated and 2 horses (2/36 eyes, 5.6%) were subjected to euthanasia. Treatment protocols were compared in the 31 eyes with ulcerative keratitis. In this group, 3/31 globes were immediately enucleated, 16/31 eyes were treated topically with voriconazole or voriconazole/fluconazole and 12/31 with other antifungal drug combinations. The different medication protocols did not significantly affect the outcome.
There were no significant differences in outcome between different medical treatment protocols or types of surgical approach.
Future studies in central Europe should focus on the identification of fungal pathogens, susceptibility patterns and the efficacy of antifungal drug therapies.
角膜炎是马的一种严重疾病。引起角膜炎的真菌在地理上存在差异,生物体对抗真菌药物的敏感性也存在差异,但关于这种疾病的先前出版物很少来自欧洲。
回顾性比较 2000 年 1 月至 2011 年 8 月在瑞士兽医大学诊断的 35 匹马 36 只眼的临床资料。评估病史、季节、先前的治疗、临床症状、手术和药物治疗、治疗持续时间和眼球存活率。
回顾性病例系列。
回顾性分析具有明确细胞学或组织学角膜炎诊断的马匹的病历。
36 只眼中 31 只(86.1%)表现为溃疡性角膜炎,2/36(5.55%)为弥漫性角膜浸润,2/36(5.55%)为浅表点状角膜炎,1/36(2.8%)为荧光素阴性真菌斑块。6 株真菌培养中有 2 株为曲霉菌属。30 只眼接受了药物和手术治疗,3 只眼仅接受了药物治疗。在 3 匹马中,在首次就诊时就摘除了眼球。性别、年龄、先前使用抗生素或类固醇治疗或手术方式均未显著影响结果。36 只眼中的 23 只(63.9%)至少部分视力正常,11/36 只眼(30.5%)行眼球摘除术,2 匹马(2/36 只眼,5.6%)实施安乐死。对 31 只溃疡性角膜炎眼进行治疗方案比较。在这组中,3/31 只眼球立即行眼球摘除术,16/31 只眼局部用伏立康唑或伏立康唑/氟康唑治疗,12/31 只眼用其他抗真菌药物联合治疗。不同的药物治疗方案对结果无显著影响。
不同的药物治疗方案或手术方式之间的结果无显著差异。
中欧未来的研究应集中于鉴定真菌病原体、敏感性模式和抗真菌药物治疗的疗效。